当前位置：首页 > 文献互助 > 互助详情

Bio-based hot-melt adhesive from xylan复制

用户penCqby_Mxmc 8小时前 45 50 已关闭

DOI: 10.1038/s41893-025-01579-9复制

文献链接: https://doi.org/10.1038/s41893-025-01579-9复制

其他信息:

出版社: Springer Science and Business Media LLC
作者: Ziwen Lv; Xueqing Yan; Siyu Jia; Jing Pan; Xiang Hao; Gegu Chen; Baozhong Lü; Jun Rao; Feng Peng
全文下载地址: https://www.nature.com/articles/s41893-025-01579-9.pdf

上一篇：BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model

下一篇：Optimization of Thienopyrimidine Derivatives as Potent and Selective PI3Kδ Inhibitors for Cancer Immunotherapy

互助时间线

2025-07-15 21:53:49 [关闭求助]

楼主用户penCqby_Mxmc关闭了求助

2025-07-15 21:46:54 [发起求助]

最新发布的求助

Machine Learning-Assisted Iterative Screening for Efficient Detection of Drug Discovery Starting Points 8小时前
What Works, What Doesn’t, and Why? An Industrial Perspective on Absorption Modeling 8小时前
Optimization of Thienopyrimidine Derivatives as Potent and Selective PI3Kδ Inhibitors for Cancer Immunotherapy 8小时前
Bio-based hot-melt adhesive from xylan 8小时前
BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model 8小时前
REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells 8小时前
BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model 8小时前
Efficacy and safety of xanomeline-trospium chloride in schizophrenia: a randomized clinical trial 8小时前
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double … 8小时前
Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators 8小时前
CRF Peptides in the Cardiovascular System 9小时前
The Receptors for CRF PeptidesCRF 肽的受体 9小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com